Current Report Filing (8-k)
October 22 2021 - 1:34PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 22, 2021
_______________________________
FUSE SCIENCE, INC.
(Exact name of registrant as specified in its charter)
_______________________________
Nevada
|
000-22991
|
87-0460247
|
(State or Other Jurisdiction
|
(Commission
|
(I.R.S. Employer
|
of Incorporation)
|
File Number)
|
Identification No.)
|
25 N. Market St. Office 110, Jacksonville, FL
32202
(Address of Principal Executive Offices) (Zip Code)
904-490-0245
(Registrant’s telephone number, including
area code)
___________________________________________
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
N/A
|
N/A
|
N/A
|
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item 8.01 - Other Events
The company wants to thank all shareholders and OTC
Markets Group in the successful journey to become Pink Current. David Delke founder of kustomeroo will work to keep everyone updated
via formal channels including Twitter @daviddelke, @kustomeroo and https://kustomeroo.com.
The company will have an investor and shareholder event on February 20th 2022 to discuss current and future partnerships along
with product roadmap and long term vision of the company. The platform used for the event will be announced soon.
The management is of the opinion that this is a
material event and as a voluntary SEC filer is making the market aware of its activities. These are the events planned for the
future of the company.
- Increase in authorized shares
- Uplist to the OTCQB
- Become SEC reporting company
- Audited financial statements
- Company name change
- FINRA symbol change
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
FUSE SCIENCE, INC.
|
|
|
|
By
|
/s/ David Delke
|
|
|
Name: David Delke
Title: President
|
Date: October 22, 2021
Fuse Science (PK) (USOTC:DROP)
Historical Stock Chart
From Dec 2024 to Jan 2025
Fuse Science (PK) (USOTC:DROP)
Historical Stock Chart
From Jan 2024 to Jan 2025